University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Decisional Quality for Patients With Coronary Artery Disease

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Behavioral: CAD Education
Behavioral: Decision Aid

First Posted Date: 2014-05-23

Last Posted Date: 2018-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 677

Registration Number: NCT02145481

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Truman Medical Center, Kansas City, Missouri, United States

and more 1 locations

Patient-Centered Care and Asian Americans

Not Applicable

Completed

Conditions: Hepatitis B
Hepatitis C
Liver Disease

Interventions: Behavioral: Video Doctor, PA + PPN

First Posted Date: 2014-05-15

Last Posted Date: 2020-07-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 431

Registration Number: NCT02139722

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Zuckerberg San Francisco General, San Francisco, California, United States

Safety Study of TPI-287 to Treat CBS and PSP

Phase 1

Completed

Conditions: Corticobasal Syndrome (CBS)
Primary Four Repeat Tauopathies (4RT)
Progressive Supranuclear Palsy (PSP)
Corticobasal Degeneration (CBD)

Interventions: Drug: TPI 287 2 mg/m2
Drug: TPI-287 20 mg/m2
Drug: Placebo
Drug: TPI-287 6.3 mg/m2

First Posted Date: 2014-05-08

Last Posted Date: 2020-04-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 44

Registration Number: NCT02133846

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

Fatigue Management in HIV

Not Applicable

Completed

Conditions: Fatigue

Interventions: Behavioral: Sleep and Rhythm Intervention
Behavioral: Dietary Modifications

First Posted Date: 2014-04-29

Last Posted Date: 2016-06-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 53

Registration Number: NCT02126007

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment

Not Applicable

Completed

Conditions: Borderline Personality Disorder

Interventions: Behavioral: Central Meditation and Imagery Therapy

First Posted Date: 2014-04-29

Last Posted Date: 2021-01-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 15

Registration Number: NCT02125942

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers

Not Applicable

Completed

Conditions: Relaxation Recording
Mentalizing Imagery Therapy

Interventions: Behavioral: Mentalizing Imagery Therapy
Behavioral: Relaxation cd

First Posted Date: 2014-04-24

Last Posted Date: 2021-01-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 26

Registration Number: NCT02122068

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Anticoagulation in AF Ablation and Effects on Neurocognitive Function

Phase 4

Withdrawn

Conditions: Cerebrothromboembolus
Atrial Fibrillation
Neurocognitive Function

Interventions: Procedure: Atrial Fibrillation Ablation

First Posted Date: 2014-04-22

Last Posted Date: 2014-12-12

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02120560

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Transforming Research and Clinical Knowledge in Traumatic Brain Injury

Completed

Conditions: Traumatic Brain Injury

Interventions: Behavioral: In-Person Outcome Assessment
Behavioral: Phone Outcome Assessment
Procedure: 3T Magnetic Resonance Imaging (MRI)
Procedure: Blood Draw for Plasma, DNA, Serum, RNA

First Posted Date: 2014-04-21

Last Posted Date: 2020-09-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2996

Registration Number: NCT02119182

Locations: 🇺🇸
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 20 locations

Urine pH and Diet Net Acid Load

Not Applicable

Withdrawn

Conditions: Healthy

Interventions: Other: high or low acid diet

First Posted Date: 2014-04-17

Last Posted Date: 2017-07-27

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02116595

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma

Phase 1

Terminated

Conditions: Retinoblastoma
Advanced Intra-Ocular Retinoblastoma

Interventions: Drug: Melphalan
Drug: Carboplatin
Drug: Etoposide
Drug: Vincristine

First Posted Date: 2014-04-17

Last Posted Date: 2020-04-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 6

Registration Number: NCT02116959

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy